My laboratory studies include immunosuppression approaches for liver transplantation and liver transplant rejection. Pediatric liver transplant rejection occurs in approximately 50 percent of recipients within the first year after the transplant.
While most rejection episodes can be treated simply and easily, rejections that happen later, at six or more months after transplantation, are more complex in terms of treatment. These rejections are more likely to result in decreased allograft and recipient survival.
Currently, we lack effective tools to properly predict rejection and determine which patients will positively respond to anti-rejection treatment and which will not. We also currently lack customized patient-specific approaches to treat rejection in an individualized manner, so as to minimize the negative outcomes of over-immune suppression.
To solve these issues, my research team and I are utilizing single-cell RNA sequencing to immunophenotype allograft-infiltrating immune cells when a patient’s body is rejecting a liver transplant. We are hopeful that our research will yield novel findings of new therapeutic targets and biomarkers for treatment response.
I was led to these research interests because of my passion for studying the immune system and how it can differentiate between the self and non-self entities. I received my PhD in Immunology from the University of Iowa, where I studied B cell signaling in viral infections and autoimmunity.
These aspects of immunology inspired my research for discovering the cellular and molecular mechanisms behind pediatric liver transplant rejection. Our research discoveries can be used to develop targeted treatments for rejection and boost long-term allograft and recipient health.
In terms of patient care, I specialize in pediatric chronic liver disease and pediatric liver transplantation. I completed my Pediatric Gastroenterology and Transplant Hepatology fellowships at Cincinnati Children's Hospital. I especially found it motivating to observe the strength of the families and the spirit of our patients before, during and after the liver transplant process.
It is extremely rewarding to work with our superb transplant team to steer patients and their families through these difficult times. I also enjoy watching children grow and flourish after a transplant.
I joined Cincinnati Children’s Hospital Medical Center in 2011, when I began my residency. I received a K12 award from the Cincinnati Children’s Hospital Medical Center for my studies. Additionally, my research has been published in multiple journals, including Transplant Infectious Disease, PLoS ONE, Pediatric Transplantation and The Journal of Pediatrics.
As an early career investigator, I am looking to expand my laboratory and engage in dynamic collaborations.
MD: University of Iowa, Iowa City, IA, 2011.
Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2014.
Fellowship: Pediatric Gastroenterology and Advanced/Transplant Hepatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2018/2019.
Certifications: Pediatrics, 2014; Pediatric Gastroenterology, 2018; Pediatric Transplant Hepatology, 2019.
Pediatric hepatology; pediatric transplant hepatology
Liver transplant rejection and tolerance; liver transplant outcomes research
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Utility of Serum Matrix Metalloproteinase-7 as a Biomarker in Cholestatic Infants with Congenital Heart Disease. Pediatric Cardiology. 2025; 46:2469-2474.
Single-cell transcriptional landscape of liver transplant rejection reveals tissue persistence of clonally expanded, treatment-resistant T cells. American Journal of Transplantation. 2025; 25:2345-2360.
Adeno-associated Virus-mediated Silencing of Sox4 Leads to Long-Term Amelioration of Liver Phenotypes in Mouse Models of Alagille Syndrome. Gastroenterology. 2025; 169:1000-1016.
Anti-Thymocyte Globulin Treatment of Steroid-Refractory T-Cell Hepatitis in Children: A Case Series. Gastro Hep Advances. 2025; 4:100793.
The Society of Pediatric Liver Transplantation (SPLIT): 2023 Registry Status. Pediatric Transplantation. 2025; 29:e70111.
Integration of scRNAseq Analyses of Kidney and Liver Allograft Rejection Enables Identification of Common and Unique Characteristics. American Journal of Transplantation. 2025; 25:s304.
Multiome Sequencing of Chronic Ductopenic Rejection Reveals Roles for Th2 Immunity and Activated Fibroblasts in Cholangiocyte Injury. American Journal of Transplantation. 2025; 25:s245.
Association Between Early Immunosuppression Center Variability and One-Year Outcomes After Pediatric Liver Transplant. Pediatric Transplantation. 2025; 29:e70018.
Distinct effects of racial and socioeconomic disparities on biliary atresia diagnosis and outcome. Journal of Pediatric Gastroenterology and Nutrition. 2024; 78:1038-1046.
Freedom isn't free: Assessing the risks and benefits of steroid-free immunosuppression regimens in pediatric liver transplantation in a real-world setting. Liver Transplantation. 2024; 30:242-243.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey